- Home
- WB vs XOMAO Comparison
WB vs XOMAO Comparison
Compare WB & XOMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WB
- XOMAO
- Stock Information
- Founded
- WB 2009
- XOMAO N/A
- Country
- WB China
- XOMAO United States
- Employees
- WB N/A
- XOMAO 13
- Industry
- WB Computer Software: Programming Data Processing
- XOMAO Biotechnology: Pharmaceutical Preparations
- Sector
- WB Technology
- XOMAO Health Care
- Exchange
- WB Nasdaq
- XOMAO Nasdaq
- Market Cap
- WB N/A
- XOMAO N/A
- IPO Year
- WB 2014
- XOMAO N/A
- Fundamental
- Price
- WB $9.73
- XOMAO $25.22
- Analyst Decision
- WB Buy
- XOMAO
- Analyst Count
- WB 6
- XOMAO 0
- Target Price
- WB $10.28
- XOMAO N/A
- AVG Volume (30 Days)
- WB 873.2K
- XOMAO N/A
- Earning Date
- WB 03-13-2025
- XOMAO N/A
- Dividend Yield
- WB N/A
- XOMAO N/A
- EPS Growth
- WB N/A
- XOMAO N/A
- EPS
- WB 1.44
- XOMAO N/A
- Revenue
- WB $1,761,517,000.00
- XOMAO N/A
- Revenue This Year
- WB $1.09
- XOMAO N/A
- Revenue Next Year
- WB $1.91
- XOMAO N/A
- P/E Ratio
- WB $6.49
- XOMAO N/A
- Revenue Growth
- WB 0.99
- XOMAO N/A
- 52 Week Low
- WB $7.03
- XOMAO N/A
- 52 Week High
- WB $12.40
- XOMAO N/A
- Technical
- Relative Strength Index (RSI)
- WB 55.21
- XOMAO 42.19
- Support Level
- WB $8.71
- XOMAO $25.08
- Resistance Level
- WB $9.48
- XOMAO $25.41
- Average True Range (ATR)
- WB 0.30
- XOMAO 0.12
- MACD
- WB 0.01
- XOMAO -0.02
- Stochastic Oscillator
- WB 85.72
- XOMAO 23.88
About XOMAO AGNC Investment Corp.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.